GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| Bioactivity Comments |
| ARGX-110 blocks CD70-CD27 signaling, and exhibits potent complement-dependent cytotoxicity and antibody-dependent cellular phagocytosis activity [2]. Blocking CD70 activation of CD27 blocks the activation and proliferation of Treg cells, and triggers T cell-mediated tumour cell destruction. Its half-life is 12 days in cynomolgus monkeys [2]. |
| Selectivity at ligand targets | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||